Featured Research

from universities, journals, and other organizations

Genomic differences identified in common skin diseases may lead to better treatments

Date:
January 2, 2010
Source:
Rockefeller University
Summary:
Scientists have drilled down on the molecular nitty-gritty that distinguishes the two most common forms of inflammatory skin disease, atopic eczema and psoriasis. The researchers say that the ability to distinguish between the disorders' genetic and immunological signatures opens the door for more narrowly targeted therapies sorely needed by the millions of people afflicted worldwide.

It's sometimes said that dermatologists do one of two things (though it's not dermatologists who say it): Faced with a skin disease that's too dry, they try to wet it; if the disease is too wet, they try to dry it. There's some wisdom in this general approach, says James G. Krueger, head of the Laboratory for Investigative Dermatology at Rockefeller University. But it also suggests the lack of sophisticated treatments for many skin conditions. "A hairdryer or a sponge doesn't make a very good therapeutic. We need to do better. We need to be more specific."

In experiments published this month in The Journal of Allergy and Clinical Immunology, Krueger and colleagues drilled down on the molecular nitty-gritty that distinguishes the two most common forms of inflammatory skin disease, atopic eczema and psoriasis. The researchers say that the ability to distinguish between the disorders' genetic and immunological signatures opens the door for more narrowly targeted therapies sorely needed by the millions of people afflicted worldwide.

A team of researchers led by Visiting Fellow Emma Guttman and Research Associate Mayte Suαrez-Fariρas used extensive genetic tests to detail the gene expression patterns in skin samples of both diseases and normal skin. They also dissected the activity that each of the diseases jump-starts in the immune system, defining the unique signaling molecules -- called cytokines -- that T cells produce in the face of each threat to direct the immune response. The scientists confirmed previously recognized immunological distinctions, but they found even more remarkable differences in the expression of genes that control the differentiation of skin cells, establishing a new paradigm for precisely classifying the diseases.

Atopic eczema is a disease that chronically inflames and irritates patches of skin, often causing "wet" lesions. It runs in families, is associated with respiratory allergies such as asthma and afflicts about 100 million people worldwide, up to 25 percent of some populations of children. Psoriasis, which is also chronic and usually produces red and scaly "dry" rashes, is even more prevalent, striking two to three percent of people around the world. The diseases generally do not respond to the same treatments, except for systemic immune suppression, which becomes dangerous if prolonged and is not approved by the Food and Drug Administration. Other existing treatments are inadequate, Guttman says.

Earlier genetic testing of eczema and psoriasis did not use enough samples to produce the statistical power needed to definitively establish how each disease differs from normal skin, the researchers say. Up to this point, scientists have focused in particular on a defect in one gene associated with some cases of eczema -- filaggrin.

Filaggrin, however, is only one of 150 to 200 genes that comprise the epidermal differentiation complex, which directs the formation of the skin's defensive barriers and cell growth more generally. The new research shows that the expression of many of these genes is suppressed in eczema, especially in those genes responsible for producing the hard, insoluble envelope surrounding skin cells. One gene, loricrin, is expressed at only two percent of its level in normal skin. Psoriasis, by contrast, generally increases the expression of many of these genes, the researchers found.

Until now, animal models have guided the development of new therapies for human skin disorders. However, it has been difficult to determine if a model simulates psoriasis, atopic eczema or some other inflammatory disorder. And so far, treatments that have shown promise in animals by and large have not translated to humans. The new research may be a game-changer. "What we've got is a means to critically evaluate the models of these diseases in animals in a way that wasn't possible before," says Krueger, who is also director of Rockefeller's Milstein Medical Research Program.

By detailing the gene expression profile of each disease and zeroing in on a key difference in how they operate at the molecular level, the research also suggests new possibilities -- narrow-acting immunosuppression drugs or treatments for the barrier around skin cells, for instance -- that might strike individual vulnerabilities in the diseases without harming the patients. "Atopic eczema is widely prevalent and understudied. We've begun a process that may take years to come to fruition, but this is where you start to look for better treatment targets," Krueger says. "You find the fundamental defects, and that's what we've done."


Story Source:

The above story is based on materials provided by Rockefeller University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Guttman-Yassky et al. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. The Journal of Allergy and Clinical Immunology, 2009; 124 (6): 1235 DOI: 10.1016/j.jaci.2009.09.031

Cite This Page:

Rockefeller University. "Genomic differences identified in common skin diseases may lead to better treatments." ScienceDaily. ScienceDaily, 2 January 2010. <www.sciencedaily.com/releases/2009/12/091231150117.htm>.
Rockefeller University. (2010, January 2). Genomic differences identified in common skin diseases may lead to better treatments. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/2009/12/091231150117.htm
Rockefeller University. "Genomic differences identified in common skin diseases may lead to better treatments." ScienceDaily. www.sciencedaily.com/releases/2009/12/091231150117.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) — The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) — A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) — Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) — As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins